Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020
Background & objectives: Population-based seroepidemiological studies measure the extent of SARS-CoV-2 infection in a country. We report the findings of the first round of a national serosurvey, conducted to estimate the seroprevalence of SARS-CoV-2 infection among adult population of India. Met...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Series: | Indian Journal of Medical Research |
Subjects: | |
Online Access: | http://www.ijmr.org.in/article.asp?issn=0971-5916;year=2020;volume=152;issue=1;spage=48;epage=60;aulast=Murhekar |
id |
doaj-3bec2a6709a6492d89b10e17b62daf5e |
---|---|
record_format |
Article |
spelling |
doaj-3bec2a6709a6492d89b10e17b62daf5e2020-11-25T02:47:29ZengWolters Kluwer Medknow PublicationsIndian Journal of Medical Research0971-59162020-01-011521486010.4103/ijmr.IJMR_3290_20Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020Manoj V MurhekarTarun BhatnagarSriram SelvarajuKiran RadeV SaravanakumarJeromie Wesley Vivian ThangarajMuthusamy Santhosh KumarNaman ShahR SabarinathanAlka TurukParveen Kumar AnandSmita AsthanaRakesh BalachandarSampada Dipak BangarAvi Kumar BansalJyothi BhatDebjit ChakrabortyChethana RangarajuVishal ChopraDasarathi DasAlok Kumar DebKangjam Rekha DeviGaurav Raj DwivediS Muhammad Salim KhanInaamul HaqM Sunil KumarAvula LaxmaiahMadhukaAmarendra MahapatraAnindya MitraA R NirmalaAvinash PagdhuneMariya Amin QurieshiTekumalla RamaraoSeema SahayY K SharmaMarinaik Basavegowdanadoddi ShrinivasaVijay Kumar ShuklaPrashant Kumar SinghAnkit ViramgamiVimith Cheruvathoor WilsonRajiv YadavC P Girish KumarHanna Elizabeth LukeUma Devi RanganathanSubash BabuKrithikaa SekarPragya D YadavGajanan N SapkalAparup DasPradeep DasShanta DuttaRajkumar HemalathaAshwani KumarKanwar NarainSomashekar NarasimhaiahSamiran PandaSanghamitra PatiShripad PatilKamalesh SarkarShalini SinghRajni KantSrikanth TripathyG S TotejaGiridhara R BabuShashi KantJ P MuliyilRavindra Mohan PandeySwarup SarkarSujeet K SinghSanjay ZodpeyRaman R GangakhedkarD C S. ReddyBalram BhargavaBackground & objectives: Population-based seroepidemiological studies measure the extent of SARS-CoV-2 infection in a country. We report the findings of the first round of a national serosurvey, conducted to estimate the seroprevalence of SARS-CoV-2 infection among adult population of India. Methods: From May 11 to June 4, 2020, a randomly sampled, community-based survey was conducted in 700 villages/wards, selected from the 70 districts of the 21 States of India, categorized into four strata based on the incidence of reported COVID-19 cases. Four hundred adults per district were enrolled from 10 clusters with one adult per household. Serum samples were tested for IgG antibodies using COVID Kavach ELISA kit. All positive serum samples were re-tested using Euroimmun SARS-CoV-2 ELISA. Adjusting for survey design and serial test performance, weighted seroprevalence, number of infections, infection to case ratio (ICR) and infection fatality ratio (IFR) were calculated. Logistic regression was used to determine the factors associated with IgG positivity. Results: Total of 30,283 households were visited and 28,000 individuals were enrolled. Population-weighted seroprevalence after adjusting for test performance was 0.73 per cent [95% confidence interval (CI): 0.34-1.13]. Males, living in urban slums and occupation with high risk of exposure to potentially infected persons were associated with seropositivity. A cumulative 6,468,388 adult infections (95% CI: 3,829,029-11,199,423) were estimated in India by the early May. The overall ICR was between 81.6 (95% CI: 48.3-141.4) and 130.1 (95% CI: 77.0-225.2) with May 11 and May 3, 2020 as plausible reference points for reported cases. The IFR in the surveyed districts from high stratum, where death reporting was more robust, was 11.72 (95% CI: 7.21-19.19) to 15.04 (9.26-24.62) per 10,000 adults, using May 24 and June 1, 2020 as plausible reference points for reported deaths. Interpretation & conclusions: Seroprevalence of SARS-CoV-2 was low among the adult population in India around the beginning of May 2020. Further national and local serosurveys are recommended to better inform the public health strategy for containment and mitigation of the epidemic in various parts of the country.http://www.ijmr.org.in/article.asp?issn=0971-5916;year=2020;volume=152;issue=1;spage=48;epage=60;aulast=Murhekarantibody - covid-19 - elisa - igg - india - sars-cov-2 - seroepidemiology - seroprevalence - serosurveillance |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Manoj V Murhekar Tarun Bhatnagar Sriram Selvaraju Kiran Rade V Saravanakumar Jeromie Wesley Vivian Thangaraj Muthusamy Santhosh Kumar Naman Shah R Sabarinathan Alka Turuk Parveen Kumar Anand Smita Asthana Rakesh Balachandar Sampada Dipak Bangar Avi Kumar Bansal Jyothi Bhat Debjit Chakraborty Chethana Rangaraju Vishal Chopra Dasarathi Das Alok Kumar Deb Kangjam Rekha Devi Gaurav Raj Dwivedi S Muhammad Salim Khan Inaamul Haq M Sunil Kumar Avula Laxmaiah Madhuka Amarendra Mahapatra Anindya Mitra A R Nirmala Avinash Pagdhune Mariya Amin Qurieshi Tekumalla Ramarao Seema Sahay Y K Sharma Marinaik Basavegowdanadoddi Shrinivasa Vijay Kumar Shukla Prashant Kumar Singh Ankit Viramgami Vimith Cheruvathoor Wilson Rajiv Yadav C P Girish Kumar Hanna Elizabeth Luke Uma Devi Ranganathan Subash Babu Krithikaa Sekar Pragya D Yadav Gajanan N Sapkal Aparup Das Pradeep Das Shanta Dutta Rajkumar Hemalatha Ashwani Kumar Kanwar Narain Somashekar Narasimhaiah Samiran Panda Sanghamitra Pati Shripad Patil Kamalesh Sarkar Shalini Singh Rajni Kant Srikanth Tripathy G S Toteja Giridhara R Babu Shashi Kant J P Muliyil Ravindra Mohan Pandey Swarup Sarkar Sujeet K Singh Sanjay Zodpey Raman R Gangakhedkar D C S. Reddy Balram Bhargava |
spellingShingle |
Manoj V Murhekar Tarun Bhatnagar Sriram Selvaraju Kiran Rade V Saravanakumar Jeromie Wesley Vivian Thangaraj Muthusamy Santhosh Kumar Naman Shah R Sabarinathan Alka Turuk Parveen Kumar Anand Smita Asthana Rakesh Balachandar Sampada Dipak Bangar Avi Kumar Bansal Jyothi Bhat Debjit Chakraborty Chethana Rangaraju Vishal Chopra Dasarathi Das Alok Kumar Deb Kangjam Rekha Devi Gaurav Raj Dwivedi S Muhammad Salim Khan Inaamul Haq M Sunil Kumar Avula Laxmaiah Madhuka Amarendra Mahapatra Anindya Mitra A R Nirmala Avinash Pagdhune Mariya Amin Qurieshi Tekumalla Ramarao Seema Sahay Y K Sharma Marinaik Basavegowdanadoddi Shrinivasa Vijay Kumar Shukla Prashant Kumar Singh Ankit Viramgami Vimith Cheruvathoor Wilson Rajiv Yadav C P Girish Kumar Hanna Elizabeth Luke Uma Devi Ranganathan Subash Babu Krithikaa Sekar Pragya D Yadav Gajanan N Sapkal Aparup Das Pradeep Das Shanta Dutta Rajkumar Hemalatha Ashwani Kumar Kanwar Narain Somashekar Narasimhaiah Samiran Panda Sanghamitra Pati Shripad Patil Kamalesh Sarkar Shalini Singh Rajni Kant Srikanth Tripathy G S Toteja Giridhara R Babu Shashi Kant J P Muliyil Ravindra Mohan Pandey Swarup Sarkar Sujeet K Singh Sanjay Zodpey Raman R Gangakhedkar D C S. Reddy Balram Bhargava Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020 Indian Journal of Medical Research antibody - covid-19 - elisa - igg - india - sars-cov-2 - seroepidemiology - seroprevalence - serosurveillance |
author_facet |
Manoj V Murhekar Tarun Bhatnagar Sriram Selvaraju Kiran Rade V Saravanakumar Jeromie Wesley Vivian Thangaraj Muthusamy Santhosh Kumar Naman Shah R Sabarinathan Alka Turuk Parveen Kumar Anand Smita Asthana Rakesh Balachandar Sampada Dipak Bangar Avi Kumar Bansal Jyothi Bhat Debjit Chakraborty Chethana Rangaraju Vishal Chopra Dasarathi Das Alok Kumar Deb Kangjam Rekha Devi Gaurav Raj Dwivedi S Muhammad Salim Khan Inaamul Haq M Sunil Kumar Avula Laxmaiah Madhuka Amarendra Mahapatra Anindya Mitra A R Nirmala Avinash Pagdhune Mariya Amin Qurieshi Tekumalla Ramarao Seema Sahay Y K Sharma Marinaik Basavegowdanadoddi Shrinivasa Vijay Kumar Shukla Prashant Kumar Singh Ankit Viramgami Vimith Cheruvathoor Wilson Rajiv Yadav C P Girish Kumar Hanna Elizabeth Luke Uma Devi Ranganathan Subash Babu Krithikaa Sekar Pragya D Yadav Gajanan N Sapkal Aparup Das Pradeep Das Shanta Dutta Rajkumar Hemalatha Ashwani Kumar Kanwar Narain Somashekar Narasimhaiah Samiran Panda Sanghamitra Pati Shripad Patil Kamalesh Sarkar Shalini Singh Rajni Kant Srikanth Tripathy G S Toteja Giridhara R Babu Shashi Kant J P Muliyil Ravindra Mohan Pandey Swarup Sarkar Sujeet K Singh Sanjay Zodpey Raman R Gangakhedkar D C S. Reddy Balram Bhargava |
author_sort |
Manoj V Murhekar |
title |
Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020 |
title_short |
Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020 |
title_full |
Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020 |
title_fullStr |
Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020 |
title_full_unstemmed |
Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020 |
title_sort |
prevalence of sars-cov-2 infection in india: findings from the national serosurvey, may-june 2020 |
publisher |
Wolters Kluwer Medknow Publications |
series |
Indian Journal of Medical Research |
issn |
0971-5916 |
publishDate |
2020-01-01 |
description |
Background & objectives: Population-based seroepidemiological studies measure the extent of SARS-CoV-2 infection in a country. We report the findings of the first round of a national serosurvey, conducted to estimate the seroprevalence of SARS-CoV-2 infection among adult population of India.
Methods: From May 11 to June 4, 2020, a randomly sampled, community-based survey was conducted in 700 villages/wards, selected from the 70 districts of the 21 States of India, categorized into four strata based on the incidence of reported COVID-19 cases. Four hundred adults per district were enrolled from 10 clusters with one adult per household. Serum samples were tested for IgG antibodies using COVID Kavach ELISA kit. All positive serum samples were re-tested using Euroimmun SARS-CoV-2 ELISA. Adjusting for survey design and serial test performance, weighted seroprevalence, number of infections, infection to case ratio (ICR) and infection fatality ratio (IFR) were calculated. Logistic regression was used to determine the factors associated with IgG positivity.
Results: Total of 30,283 households were visited and 28,000 individuals were enrolled. Population-weighted seroprevalence after adjusting for test performance was 0.73 per cent [95% confidence interval (CI): 0.34-1.13]. Males, living in urban slums and occupation with high risk of exposure to potentially infected persons were associated with seropositivity. A cumulative 6,468,388 adult infections (95% CI: 3,829,029-11,199,423) were estimated in India by the early May. The overall ICR was between 81.6 (95% CI: 48.3-141.4) and 130.1 (95% CI: 77.0-225.2) with May 11 and May 3, 2020 as plausible reference points for reported cases. The IFR in the surveyed districts from high stratum, where death reporting was more robust, was 11.72 (95% CI: 7.21-19.19) to 15.04 (9.26-24.62) per 10,000 adults, using May 24 and June 1, 2020 as plausible reference points for reported deaths.
Interpretation & conclusions: Seroprevalence of SARS-CoV-2 was low among the adult population in India around the beginning of May 2020. Further national and local serosurveys are recommended to better inform the public health strategy for containment and mitigation of the epidemic in various parts of the country. |
topic |
antibody - covid-19 - elisa - igg - india - sars-cov-2 - seroepidemiology - seroprevalence - serosurveillance |
url |
http://www.ijmr.org.in/article.asp?issn=0971-5916;year=2020;volume=152;issue=1;spage=48;epage=60;aulast=Murhekar |
work_keys_str_mv |
AT manojvmurhekar prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT tarunbhatnagar prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT sriramselvaraju prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT kiranrade prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT vsaravanakumar prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT jeromiewesleyvivianthangaraj prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT muthusamysanthoshkumar prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT namanshah prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT rsabarinathan prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT alkaturuk prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT parveenkumaranand prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT smitaasthana prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT rakeshbalachandar prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT sampadadipakbangar prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT avikumarbansal prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT jyothibhat prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT debjitchakraborty prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT chethanarangaraju prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT vishalchopra prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT dasarathidas prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT alokkumardeb prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT kangjamrekhadevi prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT gauravrajdwivedi prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT smuhammadsalimkhan prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT inaamulhaq prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT msunilkumar prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT avulalaxmaiah prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT madhuka prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT amarendramahapatra prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT anindyamitra prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT arnirmala prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT avinashpagdhune prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT mariyaaminqurieshi prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT tekumallaramarao prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT seemasahay prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT yksharma prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT marinaikbasavegowdanadoddishrinivasa prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT vijaykumarshukla prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT prashantkumarsingh prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT ankitviramgami prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT vimithcheruvathoorwilson prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT rajivyadav prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT cpgirishkumar prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT hannaelizabethluke prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT umadeviranganathan prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT subashbabu prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT krithikaasekar prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT pragyadyadav prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT gajanannsapkal prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT aparupdas prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT pradeepdas prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT shantadutta prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT rajkumarhemalatha prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT ashwanikumar prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT kanwarnarain prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT somashekarnarasimhaiah prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT samiranpanda prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT sanghamitrapati prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT shripadpatil prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT kamaleshsarkar prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT shalinisingh prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT rajnikant prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT srikanthtripathy prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT gstoteja prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT giridhararbabu prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT shashikant prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT jpmuliyil prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT ravindramohanpandey prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT swarupsarkar prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT sujeetksingh prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT sanjayzodpey prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT ramanrgangakhedkar prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT dcsreddy prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 AT balrambhargava prevalenceofsarscov2infectioninindiafindingsfromthenationalserosurveymayjune2020 |
_version_ |
1724753210786185216 |